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A b s t r a c t
Introduction: Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic option for patients with severe aortic 
stenosis (AS). However, an association between cognitive functions (CF) and health-related quality of life (HRQoL) in TAVI patients 
is still unclear.
Aim: To assess the long-term changes in CF and HRQoL in elderly patients with AS after TAVI.
Material and methods: A total of 259 patients who underwent cardiological and psychological TAVI qualification were enrolled 
and divided into the normal (n = 174) and impaired cognition group (n = 85). CF and HRQoL characteristics assessed at baseline and 
13 months were compared between groups. The analysis of multiple linear regression was performed to identify the association 
between HRQoL and CF and to assess the influence of TAVI on HRQoL.
Results: There was no difference in CF between baseline and follow-up. However, an improvement in attention functions and 
memory skills in the cognitively impaired group was noted at follow-up. In addition, HRQoL scores increased in both groups. An in-
dependent predictor associated with HRQoL was global CF (β = –213, p = 0.01), which explained 7% of CF variation. Improvements 
in all five dimensions of HRQoL, from 4.8% in self-care and up to 33.6% in pain/discomfort, were found. At follow-up, 60% of TAVI 
patients had improved health, 12% had worse health, 4% showed no change and 24% had a “mixed” change.
Conclusions: TAVI is associated with positive changes in the functioning of elderly patients at long-term follow-up.
Key words: cognitive functions, quality of life, elderly, aortic valve stenosis.
S u m m a r y
Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic option for patients with severe aortic 
stenosis (AS). However, an association between cognitive functions (CF) and health-related quality of life (HRQoL) in TAVI 
patients is still unclear. The aim of the study was to assess the evolution of CF and HRQoL in the 13-month follow-up of the 
elderly with AS after TAVI. The long-term study results show mainly positive changes in functioning of the elderly after TAVI 
treatment.
Introduction
During the last decade transcatheter aortic valve 
implantation (TAVI) has gained clinical acceptance and 
become an appealing therapeutic option for elderly pa-
tients with multiple comorbidities and disabilities, who 
are disqualified from surgical aortic valve replacement 
(SAVR) due to a very high surgical risk [1, 2]. Numerous 
randomized clinical trials comparing TAVI to SAVR have 
proved a lower complications rate, including stroke and 
mortality associated with TAVI [3–5]. Furthermore, TAVI 
patients have beneficial long-term outcomes in compar-
ison with minithoracotomy, ministernotomy and SAVR 
[6]. Once becoming symptomatic, severe aortic valve ste-
nosis has a very poor prognosis [2], resulting in progres-
sive deterioration. Impaired functional status, reduced 
health-related quality of life (HRQoL) and cognitive de-
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cline can be found simultaneously. Thus, the assessment 
of the impact of TAVI on psychological and functional do-
mains, along with mortality and morbidity, is of predomi-
nant importance [7]. Previous studies reported conflicting 
results on the assessment of cognitive functions (CF) and 
HRQoL after TAVI. 
Aim
We sought to assess the changes in CF and HRQoL in 
the long-term follow-up of patients with AS undergoing 
TAVI.
Material and methods
Inclusion and exclusion criteria and the patients’ 
flow chart are presented in Figure 1. All patients suitable 
for TAVI based on cardiological qualification underwent 
psychological assessment. Each of these patients was 
examined before TAVI by a  neuropsychologist highly 
qualified in work with cardiologic patients. Patients were 
asked to take part in a psychological interview concern-
ing demographic data, previous mental problems, family 
life and current life situation with special interest in ev-
eryday life skills and abilities. The Mini-Mental State Ex-
amination Scale (MMSE) as well as self-reported EuroQol 
5 dimensions questionnaire (EQ-5D-3L) and the Lawton 
Instrumental Activities of Daily Living (IADL) scale were 
collected. The differences in HRQoL between patients 
with stable (MMSE ≥ 24 points) and decreased (MMSE 
≤ 23 points) CF were examined. Patients after successful 
TAVI were assessed again at 13 months after the proce-
dure. According to principles based on Pareto Improve-
ment in Welfare Economics – the Pareto Classification of 
Health Change [8, 9] we compared the results in EQ-5D-
3L before and after the TAVI procedure. In this approach 
EQ-5D-3L health state is considered “better” than anoth-
er if it is better on at least one dimension and is no worse 
in any other dimension. It is deemed to be “worse” than 
another if it is worse on at least one dimension and is 
no better in any other dimension. All patients provided 
written informed consent to participate in the study. The 
protocol was approved by the local ethics committee. The 
Patients qualified to the project (n = 350)
Patients included to the study (n = 300)
Cardiological examination (n = 300) 
Figure 1. Flow chart of patients with severe aortic stenosis qualified for transcatheter aortic valve implantation
Psychological examination before TAVI  
(n = 280) 
Negative cardiological qualification  
for TAVI (n = 20) 
Positive cardiological qualification  
for TAVI (n = 280) 
Conservative treatment (n = 21) 
Negative psychological qualification  
for TAVI (n = 21) 
Positive psychological qualification  
for TAVI (n = 259) 
Death (n = 62) or patient still 
waiting for TAVI (n = 69)  
or lack of data (n = 15) 
Implemented TAVI treatment  
(n = 113) 
Psychological examination  
after TAVI (n = 63)
Exclusion criteria: 
– A lack of informed consent
– Severe dementia
–  Severe somatic state preventing 
participation in the study
–  Eyesight or hearing deficits which 
make it impossible to fill in the 
questionnaires or answer the ques-
tions asked during the interview 
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study was provided with ethical principles for clinical re-
search based on the Declaration of Helsinki with later 
amendments.
Statistical analysis
Results are presented as number of patients (per-
centage) or mean ± standard deviation. We compared 
participants’ characteristics between the normal cogni-
tion and impaired cognition group. We used the unpaired 
t-test or Mann-Whitney U-test for continuous variables 
and the c2 test for categorical variables, as appropriate. 
Changes in the EQ-5D-3L questionnaire were analyzed 
using McNemar’s test. The differences between baseline 
and follow-up responses in the VAS score were calculat-
ed with the Wilcoxon signed-rank test. Multiple linear 
regression analyses were performed to determine the 
association between HRQoL as a dependent variable and 
cognitive functioning as an independent variable adjust-
ed for baseline characteristics, i.e. age, sex, education 
level. P-values below 0.05 were considered statistically 
significant. The statistical analysis was performed using 
Statistica 13 PL (StatSoft, Inc. Tulsa, OK, USA).
Results
All the 259 patients included in the study were be-
tween 61 and 94 years old (mean age: 81.8 ±5.9 years) 
and 61% of patients were female. Demographic and clin-
ical characteristics of subgroups with different cognitive 
status are presented in Table I. Mean MMSE in the group 
with normal CF was 27.2 ±1.9 points while in the group 
with impaired cognition it was 20.2 ±2.9 points. There 
were also differences in the age (p = 0.01) and education 
level (p = 0.001). The average wait time of 4 to 5 months 
for TAVI was similar in both groups.
Changes from baseline to 13 months in quality of life, 
instrumental activities of daily living and cognitive as-
sessment scores were assessed (Table II). EQ-5D-3L and 
VAS scale total score improved over time. Moreover, such 
factors as pain/discomfort and anxiety/depression in 
the whole study group improved (lower scores mean an 
improvement); pain/discomfort in the normal cognitive 
subgroup and impaired cognitive group also improved. 
On the other hand, the mobility dimension decreased 
in the whole study group and the normal cognitive sub-
group. In IADL there was an improvement in managing 
medications in the whole group and in the normal cogni-
tive subgroup (Table II).
The overall MMSE result did not differ between base-
line and follow-up. In the MMSE subscales (orientation, 
memory, language functions, attention, visual and spatial 
skills) differences in subgroups depending on cognitive 
status were observed. There was improvement over time 
in attention functions and memory skills in the cognitive-






Age [years]¹ 80.8 ±6.2 84.1 ±4.5 0.01
Female² 106 (60) 54 (63) 0.7
Education level [years]¹ 10.2 ±4.2 7.1 ±3.1 0.001
Total TAVI wait time [months]¹ 4.2 ±3.5 4.6 ±3.6 0.8
Hypertension² 52 (91) 19 (83) 0.2
EF% before TAVI¹ 53.3 ±13.4 53.9 ±14.2 0.6
Diabetes mellitus² 20 (35) 7 (32) 0.8
Body mass index [kg/m²]¹ 26.6 ±4.6 26.1 ±3.8 0.3
Chronic kidney disease² 18 (32) 7 (30) 0.9
Chronic obstructive pulmonary disease² 5 (9) 1 (5) 0.5
Asthma² 3 (5) 1 (5) 0.9
Coronary artery disease² 44 (77) 16 (7) 0.7
Carotid artery stenosis² 8 (15) 3 (13) 0.8
Current smoker² 1 (2) 0 (0) 0.7
EuroSCORE II¹ 6.1 ±7.7 6.5 ±8.3 0.6
STS risk score¹ 4.1 ±2.2 3.8 ±1.5 0.054
EF – ejection fraction, EuroSCORE II – European System for Cardiac Operative Risk Evaluation II, STS – Society of Thoracic Surgery risk score, TAVI – transcatheter 
aortic valve implantation. ¹Mean (standard deviation), ²numbers (%).
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ly impaired group (Table II). A multiple linear regression 
analysis was applied to assess the relationship between 
HRQoL and CF (Table III). Global cognitive performance 
(MMSE) was considered an independent variable and 
was adjusted for age, sex, and education level. The model 
explained 7% of variation in the EQ-5D-3L scores. MMSE 








Baseline Follow-up P-value Baseline Follow-up P-value Baseline Follow-up P-value
Health-related quality of life:
 Mobility EQ-5D-3L 1.8 ±0.5 1.9 ±2.8 0.01 1.8 ±0.6 2.1 ±3.5 0.05 2.1 ±0.3 1.7 ±0.5 0.1
 Self-care EQ-5D-3L 1.3 ±0.5 1.3 ±1.2 0.5 1.3 ±0.5 1.4 ±1.6 0.6 1.3 ±0.5 1.3 ±0.5 0.7
 Usual activities EQ-5D-3L 1.4 ±0.6 1.3 ±0.5 0.2 1.4 ±0.6 1.1 ±0.4 0.06 1.4 ±0.6 1.5 ±0.6 0.8
 Pain/discomfort EQ-5D-3L 1.9 ±0.5 1.3 ±0.5 0.001 1.9 ±0.6 1.4 ±0.6 0.05 2.1 ±3.4 1.3 ±0.5 0.01
 Anxiety/depression EQ-5D-3L 1.8 0±.7 1.5 ±0.6 0.05 1.8 ±0.7 1.5 ±0.7 0.1 1.7 ±0.6 1.4 ±0.5 0.2
 Total score EQ-5D-3L [points] 8.1 ±1.6 6.8 ±1.9 0.001 7.9 ±1.6 6.6 ±2.1 0.01 8.4 ±1.7 7.2 ±1.6 0.05
 EQ Visual Analogue Scale 52.8 ±17.6 64.5 ±21.5 0.01 53.6 ±17.7 63.5 ±21.3 0.05 51.5 ±17.6 66.4 ±22.5 < 0.05
Instrumental activities of daily living:
 IADL using phone 2.7 ±0.6 3.2 ±2.6 0.2 2.9 ±0.2 3.6 ±3.2 0.368 2.3 ±0.8 2.5 ±0.8 0.8
 IADL walking 2.2 ±0.8 2.5 ±0.6 0.1 2.4 ±0.7 2.6 ±0.7 0.525 1.8 ±0.8 2.3 ±0.6 0.07
 IADL shopping 2.2 ±0.8 2.4 ±0.8 0.08 2.4 ±0.8 2.5 ±0.7 0.213 1.9 ±0.9 2.2 ±0.9 0.2
 IADL cooking 2.8 ±0.5 2.6 ±0.7 0.4 2.9 ±0.4 2.7 ±0.6 0.162 2.5 ±0.7 2.5 ±0.8 1.0
 IADL basic house work 2.4 ±0.6 2.6 ±0.6 0.2 2.5 ±0.6 2.7 ±0.6 0.418 2.2 ±0.6 2.5 ±0.7 0.2
 IADL laundry 2.6 ±0.6 2.6 ±0.6 0.7 2.7 ±0.6 2.7 ±0.5 0.814 2.3 ±0.5 0.8
 IADL managing medications 2.7 ±0.5 2.5 ±0.7 0.01 2.9 ±0.3 2.7 ±0.5 <0.05 2.5 ±0.8 2.1 ±0.8 0.1
 IADL managing finance 2.7 ±0.6 2.8 ±0.5 0.8 2.9 ±0.2 2.9 ±0.3 0.576 2.4 ±0.9 2.6 ±0.8 0.4
 IADL total score [points] 20.7 ±3.9 20.8 ±3.8 1.0 20.9 ±3.9 21.8 ±3.1 0.933 18.4 ±2.9 18.7±4.4 0.7
Cognitive assessment:
 MMSE total score [points] 24.9 ±3.8 25.1 ±4.6 0.7 27.2 ±1.9 26.7 ±2.6 0.2 20.7 ±2.9 22.1 ±6.1 0.3
 MMSE orientation in time and place 9.2 ±1.3 9.3 ±1.4 0.3 9.7 ±0.5 9.7 ±0.5 0.6 8.1 ±1.8 8.4 ±2.1 0.4
 MMSE memory skills 4.8 ±1.1 4.8 ±0.9 1.0 5.2 ±0.8 4.9 ±0.8 0.08 4.1 ±1.2 4.6 ±0.9 0.05
 MMSE language functions 7.4 ±1.2 8.1 ±3.7 0.2 7.8 ±1.1 7.5 ±0.8 0.4 6.5 ±1.1 9.05 ±6.4 0.1
 MMSE attention functions 3.2 ±1.6 3.2 ±1.4 0.7 3.8 ±1.3 3.6 ±1.4 0.24 1.9 ±1.3 2.5 ±1.2 0.05
 MMSE visual and spatial skills 0.6 ±0.5 0.7 ±0.4 0.07 0.7 ±0.4 0.8 ±0.4 0.3 0.5 ±0.5 0.7 ±0.5 0.1
EQ-5D-3L – EuroQual 5-Dimension 3-Level, IADL – Instrumental Activities of Daily Living, MMSE – Mini Mental State Examination.
Table III. Analysis of multiple linear regression to EQ-5D-3L
Variable Beta P-value R2 P-value
MMSE –0.213 0.01 0.072 0.01
Sex (1 – female) 0.044 0.5
Age 0.101 0.1
Education level 0.005 0.9
MMSE – Mini Mental State Examination.
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was the only independent predictor associated with the 
EQ-5D-3L (β = –213, p = 0.01).
EQ-5D-3L data before and after TAVI are presented 
in Figure 2. There was an improvement in EQ-5D-3L in 
all five dimensions: from 4.8% improvement in self-care, 
up to 33.6% in pain/discomfort. The rank of dimensions 
in terms of percentage changes from the biggest to the 
smallest improvement was as follows: pain/discomfort, 
mobility, usual activities, anxiety/depression, self-care. 
We found that 60% of TAVI patients had improved health, 
12% had worse health, 4% had no change and 24% had 
a “mixed” change.
Discussion
In this study, patients’ general CF level was stable at 
13 months after TAVI. In a  subgroup of cognitively im-
paired patients an increase in two dimensions was not-
ed. HRQoL mainly improved, especially in the pain/dis-
comfort and anxiety/depression aspects and in the scale 
of VAS on which a subjective evaluation of quality of life 
was performed. These findings suggest the impact of 
TAVI on mental function improvement.
The data showed that the impaired cognition sub-
group’s mean age was significantly higher, and their 
education level was lower in comparison to the normal 
cognition group, with no differences in chosen medical 
factors, which is in accordance with our previous pilot 
study group characteristics [10]. Younger age and longer 
education time are the common protective factors against 
dementia which strengthen everyday life activity skills, 
independence and autonomy. Our results are in line with 
those proving preserved neurocognitive domains longi-
tudinally after TAVI [11–14]. Musa et al. [11] in an obser-
vational two-center comparison found a decline in verbal 
memory and psychomotor speed at 30 days in a group of 
patients who received a second-generation Lotus valve. 
There was a  higher incidence of silent cerebral micro-
infarction and a  greater number of lesions per patient 
following Lotus compared with CoreValve, too. However, 
performance longitudinally at 1 year was preserved in all 
neurocognitive domains with either prosthesis. Other 
studies presented [14, 15] cognitive improvement after 
TAVI in patients with initially impaired preprocedural CF. 
Change in mental status was possibly related to hemo-
dynamic improvement. Likewise, in a study by Pelletier 
et al. [12] in a subgroup analysis of patients who were 
cognitively impaired at baseline, a significant increase in 
their overall score was noted. In contrast, overall CF did 
not differ before TAVI as compared to 6 months following 
the procedure. Ciuca et al. [13] obtained data showing no 
significant differences in cognitive status from baseline 
up to 1-year follow-up. Finally, a meta-analysis by Khan 
et al. [16] showed preserved cognitive performance after 
TAVI, suggesting that this treatment is not detrimental 
to cognition.
In the more detailed analysis, we found that such 
cognitive domains as memory skills and attention func-
tions improved after TAVI in the subgroup of patients 
with cognitive impairment. Cognitive improvement in 
the group of patients with cognitive impairment at base-
line seems to be of great importance considering data 
indicating that cognitive impairment based on the MMSE 
score was an independent predictor of mortality at 1 year 
after TAVI [17]. Better memory and attention functions 
possibly also improve everyday communication and co-
operation between an elderly patient and a  caregiver 
in usual activities, self-care and other activities of daily 
living. Preserved cognitive performance after TAVI sug-
gests effectiveness of this treatment, even though the 
incidence of silent cerebral microinfarctions, lesions and 
hypoperfusion in the central nervous system as side ef-
fects are mentioned in some studies [11, 14].
CF remained at the same level or improved in all TAVI 
patients in the 13-month follow-up. Hereby, the results 
of our study also confirm that TAVI can be protective 































 Mobility Self-care Usual  Pain/ Anxiety/
   activities discomfort depression
 Mobility Self-care   Usual  Pain/ Anxiety/
     activities discomfort depression
 p < 0.001 p = 0.71    p = 0.020 p < 0.01 p = 0.023
A B
 Pre Post D Pre Post D Pre Post D Pre Post D Pre Post D
 Extreme 5% 0% –5% 2% 2% 0% 5% 3% –2% 13% 2% –11% 9% 10% 1%
 Moderate 73% 53% –20% 24% 19% –4% 36% 20% –16% 57% 35% –23% 45% 31% –14%
 None 22% 47% 25% 74% 79% 5% 59% 77% 18% 30% 64% 34% 46% 59% 13%
 Pre Post Pre Post Pre Post Pre Post Pre Post
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against the process of physiological aging of the central 
nervous system possibly due to improved hemodynamic 
functions. Measurement of general CF, as a factor of frail-
ty, seems to be of a great importance in the evaluation 
of mortality and delirium risk after TAVI. Thus, it might 
be incorporated into the risk models for preoperative as-
sessment. The frailty factors consist of e.g. general cogni-
tive functioning, activities of daily living, and motor skills 
[16–19]. TAVI guidelines [1] advocated including frailty in 
the risk models as the Frailty Index was proved to be as-
sociated with delirium after TAVI and mortality [18–23].
In this study, all TAVI patients improved their global 
HRQoL measured with EQ-5D-3L in 13-month follow-up 
and no difference was found in the global HRQoL when 
measured with IADL. From the subjective patients’ point 
of view, their quality of life level in the aspects of phys-
ical, emotional and psychological activity are at least 
as important as medical surgery results. Thus, we ana-
lyzed particular HRQoL dimensions and found that pain/
discomfort and anxiety/depression decreased after the 
TAVI procedure. The available data on HRQoL in general 
and when measured in detail showed similar outcomes 
[2, 24, 25]. In the German Aortic Valve Registry Lange 
et al. [24] concluded that TAVI led to improvements in 
HRQoL, especially in terms of mobility and usual activi-
ties. However, there was a sizable group of patients who 
did not derive any HRQoL benefits. Several independent 
pre- and post-operative factors were identified as being 
predictive for less pronounced HRQoL benefits. Deutsch 
et al. [2] stated that TAVI significantly improved HRQoL in 
high-surgical-risk patients with severe AS with sustained 
effects up to 2 years. In a comprehensive literature re-
view Ferrari et al. [25] stated that most studies report-
ed a significant increase in HRQoL after TAVI, greater for 
physical aspects compared with psychological compo-
nents, which persisted at mid and long-term follow-up. 
The author also mentioned that evaluation of quality of 
life in TAVI patients might be challenging. Similar results 
were obtained by Tokarek et al. [26]: global, physical and 
emotional dimension scores in HRQoL at 30 days from 
aortic valve replacement (AVR) presented significant im-
provement after TAVI in comparison with surgical meth-
ods 1 year after the procedure with no differences in so-
matic and emotional components. No differences were 
found in HRQoL 24 months after AVR. Also, Li et al. [27] in 
a systematic review of HRQoL changes in the long-term 
follow-up stated that this technique provides a promis-
ing therapeutic approach for elderly patients with severe 
symptomatic AS and high surgical risk.
Data from our study demonstrated significant im-
provement of HRQoL at follow-up after TAVI in compari-
son with surgical methods. However, the dimension mo-
bility-walking of HRQoL decreased in time, which is the 
opposite result to other studies [18, 24]. We suppose that 
methods such as gait speed and Timed Up and Go tests 
turned out to be more relevant than the subjective eval-
uation of mobility method in our study.
Results in HRQoL with the IADL scale showed an im-
provement in one dimension, managing medications, in 
the group of patients with a stable cognitive state. The 
ability to have control over medical treatment is import-
ant and helpful in the patients’ daily living, especially 
when we take into consideration the multiple comorbidi-
ties they suffer from and the number of medications they 
are prescribed. In a previous pilot study of TAVI patients 
[10] we put stress on the fact that psychological evalu-
ation of CF and HRQoL assessment is helpful and very 
often of great importance in the qualification process 
concerning clinical decisions and choice of treatment 
method. Furthermore, well-adjusted questionnaires are 
able to exclude those patients who cannot cooperate 
well enough during diagnostic procedures because of 
dementia. Identification of such patients would allow 
the Heart Team and treating physicians to better inform 
patients of their likely individual benefits from this proce-
dure. Therefore, comprehensive medical and psychologi-
cal evaluation of the elderly seems to be needed.
We believe that our findings support the use of TAVI 
as a therapeutic option in elderly patients who were de-
nied surgery because of advanced age, multiple comor-
bidities and surgical risk.
The main limitation of this study is the small number 
of patients in the post-TAVI group. There is a potential 
bias caused by the patients lost during follow-up, too. 
Different and more relevant methods to measure mobil-
ity changes after TAVI, instead of the subjective evalu-
ation method used in our study, should be considered.
Conclusions
Long-term results after TAVI are associated with pos-
itive changes in functioning of elderly patients. These 
findings support the importance of mental status eval-
uation before the TAVI procedure. CF and HRQoL evalua-
tion play an important role in TAVI qualification and the 
long-term observation process.
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